A detailed history of Roanoke Asset Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Roanoke Asset Management Corp holds 56,019 shares of BMY stock, worth $3.23 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
56,019
Previous 58,464 4.18%
Holding current value
$3.23 Million
Previous $2.43 Million 19.36%
% of portfolio
0.91%
Previous 0.8%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$39.66 - $51.75 $96,968 - $126,528
-2,445 Reduced 4.18%
56,019 $2.9 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $31,193 - $41,067
-775 Reduced 1.31%
58,464 $2.43 Million
Q1 2024

May 08, 2024

SELL
$47.98 - $54.4 $6,957 - $7,888
-145 Reduced 0.24%
59,239 $3.21 Million
Q4 2023

Feb 08, 2024

SELL
$48.48 - $57.85 $824 - $983
-17 Reduced 0.03%
59,384 $3.05 Million
Q3 2023

Nov 15, 2023

SELL
$57.89 - $64.73 $10,593 - $11,845
-183 Reduced 0.31%
59,401 $3.45 Million
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $382 - $424
6 Added 0.01%
59,584 $3.81 Million
Q1 2023

May 02, 2023

BUY
$65.71 - $74.53 $65 - $74
1 Added 0.0%
59,578 $4.13 Million
Q4 2022

Feb 08, 2023

SELL
$68.48 - $81.09 $202,700 - $240,026
-2,960 Reduced 4.73%
59,577 $4.29 Million
Q3 2022

Nov 03, 2022

BUY
$0.13 - $76.84 $0 - $384
5 Added 0.01%
62,537 $4.45 Million
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $765,051 - $842,589
10,535 Added 20.26%
62,532 $4.82 Million
Q1 2022

May 11, 2022

SELL
$61.48 - $73.72 $140,112 - $168,007
-2,279 Reduced 4.2%
51,997 $3.8 Million
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $127,424 - $148,547
2,376 Added 4.58%
54,276 $3.38 Million
Q3 2021

Nov 03, 2021

BUY
$59.17 - $69.31 $887 - $1,039
15 Added 0.03%
51,900 $3.07 Million
Q2 2021

Jul 28, 2021

BUY
$61.91 - $67.42 $471,444 - $513,403
7,615 Added 17.2%
51,885 $3.47 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $80,999 - $91,100
1,365 Added 3.18%
44,270 $2.8 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $18,476 - $20,937
320 Added 0.75%
42,905 $2.66 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $18,377 - $20,364
320 Added 0.76%
42,585 $2.57 Million
Q2 2020

Aug 05, 2020

SELL
$54.82 - $64.09 $132,719 - $155,161
-2,421 Reduced 5.42%
42,265 $2.49 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $10,904 - $15,846
-235 Reduced 0.52%
44,686 $2.49 Million
Q4 2019

Feb 05, 2020

SELL
$49.21 - $64.19 $349,341 - $455,684
-7,099 Reduced 13.65%
44,921 $2.88 Million
Q3 2019

Nov 01, 2019

SELL
$42.77 - $50.71 $45,763 - $54,259
-1,070 Reduced 2.02%
52,020 $2.64 Million
Q2 2019

Jul 19, 2019

SELL
$44.62 - $49.34 $10,262 - $11,348
-230 Reduced 0.43%
53,090 $2.41 Million
Q4 2018

Feb 06, 2019

SELL
$48.76 - $63.23 $33,888 - $43,944
-695 Reduced 1.29%
53,320 $2.77 Million
Q3 2018

Oct 30, 2018

SELL
$55.19 - $62.25 $1,103 - $1,245
-20 Reduced 0.04%
54,015 $3.35 Million
Q2 2018

Jul 25, 2018

BUY
$50.53 - $62.98 $115,461 - $143,909
2,285 Added 4.42%
54,035 $2.99 Million
Q1 2018

Apr 19, 2018

SELL
$59.92 - $68.98 $80,892 - $93,123
-1,350 Reduced 2.54%
51,750 $3.27 Million
Q4 2017

Jan 29, 2018

SELL
$59.94 - $65.35 $499,000 - $544,038
-8,325 Reduced 13.55%
53,100 $3.25 Million
Q3 2017

Oct 20, 2017

BUY
$55.23 - $63.74 $3.39 Million - $3.92 Million
61,425
61,425 $3.92 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Roanoke Asset Management Corp Portfolio

Follow Roanoke Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roanoke Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Roanoke Asset Management Corp with notifications on news.